---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-029840"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2021-11-24T23:59:59+00:00"
generated_at: "2026-06-28T05:29:12.937678+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Panacea Life Sciences secures $1M via convertible note and warrant sale to Lincoln Park Capital

## Summary
- Sold $1.1M senior convertible note (net $1M) and warrants for 785,715 shares at $1.40 to Lincoln Park Capital Fund.
- Note due Nov 18, 2022; 12% interest if SEC filings missed, 18% on default; conversion at $1.40.
- Warrants exercisable from May 18, 2022 for 5 years at $1.40; 4.99% beneficial ownership cap.
- Investor may buy an additional $1.1M note and warrants on same terms within 91 business days.

## SEC filing metadata
- accession: 0001493152-21-029840
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2021-11-24T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/0001493152-21-029840-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-029840
- JSON: https://secwatch.observer/filing/0001493152-21-029840.json
- Plain text: https://secwatch.observer/filing/0001493152-21-029840.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.